NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 216 filers reported holding NEKTAR THERAPEUTICS in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $468,672 | -2.0% | 814,799 | +19.7% | 0.00% | -50.0% |
| Q1 2023 | $478,333 | +357.4% | 680,514 | +1370.6% | 0.00% | – |
| Q4 2022 | $104,584 | -75.4% | 46,276 | -65.1% | 0.00% | -100.0% |
| Q3 2022 | $425,000 | -45.3% | 132,713 | -8.0% | 0.00% | -33.3% |
| Q1 2022 | $777,000 | -64.2% | 144,226 | -10.2% | 0.00% | -50.0% |
| Q4 2021 | $2,170,000 | +918.8% | 160,629 | +1252.7% | 0.01% | +500.0% |
| Q3 2021 | $213,000 | -86.0% | 11,875 | -86.6% | 0.00% | -83.3% |
| Q2 2021 | $1,519,000 | +285.5% | 88,501 | +349.4% | 0.01% | +200.0% |
| Q1 2021 | $394,000 | -27.6% | 19,695 | -38.5% | 0.00% | -50.0% |
| Q4 2020 | $544,000 | -45.1% | 32,010 | -46.4% | 0.00% | -69.2% |
| Q3 2020 | $990,000 | -28.3% | 59,700 | -22.8% | 0.01% | -62.9% |
| Q1 2020 | $1,380,000 | -47.7% | 77,334 | -36.8% | 0.04% | +118.8% |
| Q4 2019 | $2,639,000 | -32.4% | 122,283 | -42.9% | 0.02% | -54.3% |
| Q3 2019 | $3,903,000 | -20.0% | 214,299 | +44.3% | 0.04% | -38.6% |
| Q4 2018 | $4,880,000 | -65.8% | 148,478 | -36.6% | 0.06% | -66.7% |
| Q3 2018 | $14,281,000 | +407.3% | 234,267 | +306.4% | 0.17% | +362.2% |
| Q2 2018 | $2,815,000 | +946.5% | 57,648 | +319.4% | 0.04% | +640.0% |
| Q2 2017 | $269,000 | -29.0% | 13,745 | -37.6% | 0.01% | -80.0% |
| Q3 2016 | $379,000 | +101.6% | 22,032 | +66.9% | 0.02% | +108.3% |
| Q2 2016 | $188,000 | -77.5% | 13,198 | -78.2% | 0.01% | -81.5% |
| Q1 2016 | $834,000 | – | 60,665 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |